The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle
Abstract
The overt effects of the anti‐cancer drugs cisplatin (cis‐DDP) and taxol appear to be DNA modification and microtubule stabilization respectively, yet the mechanisms by which these drugs elicit tumor cell death are not well understood. In this report cell sensitivities to cis‐DDP and taxol were accurately determined as a function of cell proliferation and cell cycle stage. Quiescent fibroblasts restimulated to synchronously enter the cell cycle become maximally sensitive to cis‐DDP immediately preceding DNA synthesis, and resistance increases with onset of DNA synthesis. Mid‐log proliferating cells were separated into progressive stages of the cell cycle by centrifugal elutriation or by double thymidine (dThd) block. Cells staged by either method are maximally sensitive to cis‐DDP in G 1, just prior to the onset of DNA synthesis and minimally sensitive in peak DNA synthesis, with entry into S phase resulting in a 2‐fold decrease in sensitivity. Cells that remained blocked at the G 1/S phase boundary during cis‐DDP treatment remain maximally sensitive after release. Sensitivity to taxol increases at 2 points: transiently during transition of normal cells from quiescence to proliferation and steadily as proliferating cells progress from early G 1 to late G 2. This 3‐fold increase in taxol sensitivity through the cell cycle is rapidly reversed upon cell division. Synchronous cells treated with either drug at points of maximum sensitivity initiate apoptotic DNA fragmentation 12‐14 hr post‐exposure to drug. © 1994 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jost, L. M., Kirkwood, J. M., & Whiteside, T. L. (1992) · Journal of Immunological Methods · doi:10.1016/s0022-1759(12)80003-2 · Cited by 182
Cited by
Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide
Zhang, W., Guo, Z., Huang, D., Liu, Z., Guo, X., & Zhong, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.071 · Cited by 891
Axel, D. I., Kunert, W., Göggelmann, C., Oberhoff, M., Herdeg, C., Küttner, A., Wild, D. H., Brehm, B. R., Riessen, R., Köveker, G., et al. (1997) · Circulation · doi:10.1161/01.cir.96.2.636 · Cited by 784
Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis
Wahl, A. F., Donaldson, K. L., Faircnild, C., Lee, F. Y. F., Foster, S. A., Demers, G. W., & Galloway, D. A. (1996) · Nature Medicine · doi:10.1038/nm0196-72 · Cited by 646
Self-citationPharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Gazzerro, P., Proto, M. C., Gangemi, G., Malfitano, A. M., Ciaglia, E., Pisanti, S., Santoro, A., Laezza, C., & Bifulco, M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004994 · Cited by 457
Molecular effects of paclitaxel: Myths and reality (a critical review)
Blagosklonny, M. V., & Fojo, T. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991008)83:2<151::aid-ijc1>3.0.co;2-5 · Cited by 363
Metadata
- Authors
- Donaldson, K. L., Goolsby, G. L., & Wahl, A. F.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1994-06-15
- Volume
- 57
- Issue
- 6
- Pages
- 847-855
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2069764898
- Cited by
- 192
- References
- 1
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. https://app.cochat.ai/papers/10.1002/ijc.2910570614
- The paper
- Donaldson, K. L., Goolsby, G. L., & Wahl, A. F. (1994). Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. International Journal of Cancer. https://doi.org/10.1002/ijc.2910570614
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.